170 related articles for article (PubMed ID: 16174081)
1. Racial differences in Helicobacter pylori, serum pepsinogen and gastric cancer incidence in an urban Asian population.
Ang TL; Fock KM; Dhamodaran S; Teo EK; Tan J
J Gastroenterol Hepatol; 2005 Oct; 20(10):1603-9. PubMed ID: 16174081
[TBL] [Abstract][Full Text] [Related]
2. Low serum pepsinogen I and pepsinogen I/II ratio and Helicobacter pylori infection are associated with increased risk of gastric cancer: 14-year follow up result in a rural Chinese community.
Zhang X; Xue L; Xing L; Wang J; Cui J; Mi J; Xing X; Wang J; Du Z; Misumi J; Tian Q; Wang L
Int J Cancer; 2012 Apr; 130(7):1614-9. PubMed ID: 21547904
[TBL] [Abstract][Full Text] [Related]
3. Risk of gastric cancer in asymptomatic, middle-aged Japanese subjects based on serum pepsinogen and Helicobacter pylori antibody levels.
Yanaoka K; Oka M; Yoshimura N; Mukoubayashi C; Enomoto S; Iguchi M; Magari H; Utsunomiya H; Tamai H; Arii K; Yamamichi N; Fujishiro M; Takeshita T; Mohara O; Ichinose M
Int J Cancer; 2008 Aug; 123(4):917-26. PubMed ID: 18508314
[TBL] [Abstract][Full Text] [Related]
4. Receiver operating characteristic analysis of prediction for gastric cancer development using serum pepsinogen and Helicobacter pylori antibody tests.
Hamashima C; Sasazuki S; Inoue M; Tsugane S;
BMC Cancer; 2017 Mar; 17(1):183. PubMed ID: 28279154
[TBL] [Abstract][Full Text] [Related]
5. Serum pepsinogen values and Helicobacter pylori status among control subjects of a nested case-control study in the JACC study.
Kikuchi S; Yagyu K; Obata Y; Yingsong L; Yatsuya H; Hoshiyama Y; Kondo T; Sakata K; Mizoue T; Tokui N; Fujino Y; Tamakoshi A; Toyoshima H; Ishibashi T; Hayakawa N; Yoshimura T;
J Epidemiol; 2005 Jun; 15 Suppl 2(Suppl II):S126-33. PubMed ID: 16127224
[TBL] [Abstract][Full Text] [Related]
6. Racial differences in Helicobacter pylori seroprevalence in Singapore: correlation with differences in peptic ulcer frequency.
Kang JY; Yeoh KG; Ho KY; Guan R; Lim TP; Quak SH; Wee A; Teo D; Ong YW
J Gastroenterol Hepatol; 1997 Oct; 12(9-10):655-9. PubMed ID: 9407329
[TBL] [Abstract][Full Text] [Related]
7. Helicobacter pylori, pepsinogen, and gastric adenocarcinoma in Hawaii.
Nomura AM; Kolonel LN; Miki K; Stemmermann GN; Wilkens LR; Goodman MT; Perez-Perez GI; Blaser MJ
J Infect Dis; 2005 Jun; 191(12):2075-81. PubMed ID: 15897993
[TBL] [Abstract][Full Text] [Related]
8. Cancer development based on chronic active gastritis and resulting gastric atrophy as assessed by serum levels of pepsinogen and Helicobacter pylori antibody titer.
Yoshida T; Kato J; Inoue I; Yoshimura N; Deguchi H; Mukoubayashi C; Oka M; Watanabe M; Enomoto S; Niwa T; Maekita T; Iguchi M; Tamai H; Utsunomiya H; Yamamichi N; Fujishiro M; Iwane M; Takeshita T; Ushijima T; Ichinose M
Int J Cancer; 2014 Mar; 134(6):1445-57. PubMed ID: 24009139
[TBL] [Abstract][Full Text] [Related]
9. Combination of Helicobacter pylori Antibody and Serum Pepsinogen as a Good Predictive Tool of Gastric Cancer Incidence: 20-Year Prospective Data From the Hisayama Study.
Ikeda F; Shikata K; Hata J; Fukuhara M; Hirakawa Y; Ohara T; Mukai N; Nagata M; Yoshida D; Yonemoto K; Esaki M; Kitazono T; Kiyohara Y; Ninomiya T
J Epidemiol; 2016 Dec; 26(12):629-636. PubMed ID: 27265836
[TBL] [Abstract][Full Text] [Related]
10. Effect of Helicobacter pylori infection combined with CagA and pepsinogen status on gastric cancer development among Japanese men and women: a nested case-control study.
Sasazuki S; Inoue M; Iwasaki M; Otani T; Yamamoto S; Ikeda S; Hanaoka T; Tsugane S;
Cancer Epidemiol Biomarkers Prev; 2006 Jul; 15(7):1341-7. PubMed ID: 16835334
[TBL] [Abstract][Full Text] [Related]
11. Serum Helicobacter pylori CagA antibody titer as a useful marker for advanced inflammation in the stomach in Japan.
Shiota S; Murakami K; Okimoto T; Kodama M; Yamaoka Y
J Gastroenterol Hepatol; 2014 Jan; 29(1):67-73. PubMed ID: 24033876
[TBL] [Abstract][Full Text] [Related]
12. Helicobacter pylori infection and markers of gastric cancer risk in Alaska Native persons: a retrospective case-control study.
Keck JW; Miernyk KM; Bulkow LR; Kelly JJ; McMahon BJ; Sacco F; Hennessy TW; Bruce MG
Can J Gastroenterol Hepatol; 2014 Jun; 28(6):305-10. PubMed ID: 24945184
[TBL] [Abstract][Full Text] [Related]
13. Combining the serum pepsinogen level and Helicobacter pylori antibody test for predicting the histology of gastric neoplasm.
Choi HS; Lee SY; Kim JH; Sung IK; Park HS; Shim CS; Jin CJ
J Dig Dis; 2014 Jun; 15(6):293-8. PubMed ID: 24602176
[TBL] [Abstract][Full Text] [Related]
14. Plasma pepsinogens, antibodies against Helicobacter pylori, and risk of gastric cancer in the Shanghai Women's Health Study Cohort.
Abnet CC; Zheng W; Ye W; Kamangar F; Ji BT; Persson C; Yang G; Li HL; Rothman N; Shu XO; Gao YT; Chow WH
Br J Cancer; 2011 Apr; 104(9):1511-6. PubMed ID: 21407214
[TBL] [Abstract][Full Text] [Related]
15. Seroprevalence of Helicobacter pylori, incidence of gastric cancer, and peptic ulcer-associated hospitalizations in a Canadian Indian population.
Bernstein CN; McKeown I; Embil JM; Blanchard JF; Dawood M; Kabani A; Kliewer E; Smart G; Coghlan G; MacDonald S; Cook C; Orr P
Dig Dis Sci; 1999 Apr; 44(4):668-74. PubMed ID: 10219820
[TBL] [Abstract][Full Text] [Related]
16. Predominant mucosal IL-8 mRNA expression in non-cagA Thais is risk for gastric cancer.
Yamada S; Kato S; Matsuhisa T; Makonkawkeyoon L; Yoshida M; Chakrabandhu T; Lertprasertsuk N; Suttharat P; Chakrabandhu B; Nishiumi S; Chongraksut W; Azuma T
World J Gastroenterol; 2013 May; 19(19):2941-9. PubMed ID: 23704827
[TBL] [Abstract][Full Text] [Related]
17. Seroprevalence of Helicobacter pylori infection and gastric mucosal atrophy in Bhutan, a country with a high prevalence of gastric cancer.
Shiota S; Mahachai V; Vilaichone RK; Ratanachu-Ek T; Tshering L; Uchida T; Matsunari O; Yamaoka Y
J Med Microbiol; 2013 Oct; 62(Pt 10):1571-1578. PubMed ID: 23831768
[TBL] [Abstract][Full Text] [Related]
18. Fasting gastric pH of Japanese subjects stratified by IgG concentration against Helicobacter pylori and pepsinogen status.
Kishikawa H; Nishida J; Ichikawa H; Kaida S; Takarabe S; Matsukubo T; Miura S; Morishita T; Hibi T
Helicobacter; 2011 Dec; 16(6):427-33. PubMed ID: 22059393
[TBL] [Abstract][Full Text] [Related]
19. Helicobacter pylori and Schistosoma japonicum co-infection in a Chinese population: helminth infection alters humoral responses to H. pylori and serum pepsinogen I/II ratio.
Du Y; Agnew A; Ye XP; Robinson PA; Forman D; Crabtree JE
Microbes Infect; 2006 Jan; 8(1):52-60. PubMed ID: 16260169
[TBL] [Abstract][Full Text] [Related]
20. Helicobacter pylori infection-negative gastric cancer in Japanese hospital patients: incidence and pathological characteristics.
Kato S; Matsukura N; Tsukada K; Matsuda N; Mizoshita T; Tsukamoto T; Tatematsu M; Sugisaki Y; Naito Z; Tajiri T
Cancer Sci; 2007 Jun; 98(6):790-4. PubMed ID: 17470129
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]